180 related articles for article (PubMed ID: 3975062)
1. [Flaccid paralysis following oral poliomyelitis vaccination].
Sigmund J; Guggenbichler JP
Padiatr Padol; 1985; 20(1):77-82. PubMed ID: 3975062
[TBL] [Abstract][Full Text] [Related]
2. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
Hidalgo S; García Erro M; Cisterna D; Freire MC
Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
4. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(40):874-5. PubMed ID: 11666115
[TBL] [Abstract][Full Text] [Related]
5. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
6. Importation of wild poliovirus into Qinghai Province--China, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Feb; 49(6):113-4. PubMed ID: 11243437
[TBL] [Abstract][Full Text] [Related]
7. Poliomyelitis in Oman: acute flaccid paralysis surveillance leading to early detection and rapid response to a type 3 outbreak.
Robertson SE; Suleiman AJ; Mehta FR; al-Dhahry SH; el-Bualy MS
Bull World Health Organ; 1994; 72(6):907-14. PubMed ID: 7867136
[TBL] [Abstract][Full Text] [Related]
8. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
9. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
10. [Poliomyelitis surveillance in Shandong Province from 1991-1994].
Xu AQ; Li L; Lei J
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Dec; 16(6):354-8. PubMed ID: 8728956
[TBL] [Abstract][Full Text] [Related]
11. Lessons from diagnostic investigations of patients with poliomyelitis and their direct contacts for the present surveillance of acute flaccid paralysis.
Herremans T; Koopmans MP; van der Avoort HG; van Loon AM
Clin Infect Dis; 1999 Oct; 29(4):849-54. PubMed ID: 10589902
[TBL] [Abstract][Full Text] [Related]
12. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
[TBL] [Abstract][Full Text] [Related]
13. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
[TBL] [Abstract][Full Text] [Related]
15. [Acute flaccid paralysis after drug injection: a case report in the pediatric service of the Befelatanana Hospital Center in Antananarivo].
Rasamoelisoa JM; Tovone XG; Rakotovao E; Razafimandimby D; Rakotoarimanana DR; Andriambao D
Arch Inst Pasteur Madagascar; 2000; 66(1-2):58-60. PubMed ID: 12463038
[TBL] [Abstract][Full Text] [Related]
16. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(38):913-6. PubMed ID: 14508441
[TBL] [Abstract][Full Text] [Related]
17. Poliomyelitis surveillance in Shandong Province, China, 1990-92.
Chiba Y; Xu A; Li L; Lei T; Takezaki T; Hagiwara A; Yoneyama T; Fujiwara T; Hara M; Yamamoto T
Bull World Health Organ; 1994; 72(6):915-20. PubMed ID: 7867137
[TBL] [Abstract][Full Text] [Related]
18. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis.
Kindberg E; Ax C; Fiore L; Svensson L
J Med Virol; 2009 May; 81(5):933-6. PubMed ID: 19319949
[TBL] [Abstract][Full Text] [Related]
19. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
[TBL] [Abstract][Full Text] [Related]
20. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM
Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
